This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul;89(1):99-104.
doi: 10.4269/ajtmh.13-0103. Epub 2013 May 28.

Performance of the tourniquet test for diagnosing dengue in Peru

Affiliations

Performance of the tourniquet test for diagnosing dengue in Peru

Eric S Halsey et al. Am J Trop Med Hyg. 2013 Jul.

Abstract

The tourniquet test (TT) is a physical examination maneuver often performed on patients suspected of having dengue. It has been incorporated into dengue diagnostic guidelines and is used in clinical studies. However, little is known about TT performance characteristics in different patient types or epidemiologic conditions. In the dengue-endemic city of Iquitos, Peru, we performed TTs and dengue laboratory assays on 13,548 persons with febrile disease, recruited through either active (n = 1,095) or passive (n = 12,453) surveillance. The sensitivity was 52% and 56%, the specificity was 58% and 68%, the positive predictive value was 45% and 55%, and the negative predictive value was 64% and 69% for persons enrolled in active and passive surveillance, respectively. We demonstrated that the TT was more sensitive identifying dengue disease in women and those of younger age and that sensitivity increased the later a person came to a medical clinic for care.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have declared that no competing interests exist. The corresponding author had full access to all data in the study and final responsibility for the decision to submit this publication. Eric S. Halsey and Tadeusz J. Kochel are military service members and Stalin Vilcarromero, Isabel Bazan, and Claudio Rocha are employees of the U.S. Government. This work was prepared as part of their official duties. Title 17 U.S.C. § 105 provides that "Copyright protection under this title is not available for any work of the United States Government." Title 17 U.S.C. § 101 defines a U.S. Government work as a work prepared by a military service members or employees of the U.S. Government as part of those persons' official duties.

Figures

Figure 1.
Figure 1.
Monthly tourniquet test positive predictive value (PPV, solid line) and negative predictive value (NPV, dashed line) for dengue, Peru, 2002–2011. Vertical dashed lines demarcate the start of each year. Shaded areas indicate time periods of elevated dengue transmission (two or more consecutive months where dengue cases [absolute cases or as a proportion of all febrile cases] exceed the median for the study period). Breaks indicate months (September 2005 and November 2007) where no data were available.
Figure 2.
Figure 2.
Sensitivity and specificity of the tourniquet test in diagnosing dengue based on which day a person with febrile disease initially came for care at a medical clinic (passive surveillance), Peru. Error bars indicate 95% confidence intervals for tourniquet test sensitivity and specificity at each day post-onset.
Figure 3.
Figure 3.
Sensitivity and specificity of the tourniquet test in diagnosing dengue disease in febrile persons seeking care at medical clinics (passive surveillance) for different age groups, Peru. Error bars indicate 95% confidence intervals for tourniquet test sensitivity and specificity for each age group.
Figure 4.
Figure 4.
Sensitivity of tourniquet test in persons with dengue detected through active surveillance and tested on multiple consecutive days. Each curve represents a tourniquet test result on the first day of presentation and subsequent days. Results are organized based on day of presentation.

References

    1. Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, Moyes CL, Farlow AW, Scott TW, Hay SI. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012;6:e1760. - PMC - PubMed
    1. Potts JA, Rothman AL. Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations. Trop Med Int Health. 2008;13:1328–1340. - PMC - PubMed
    1. Gregory CJ, Lorenzi OD, Colon L, Garcia AS, Santiago LM, Rivera RC, Bermudez LJ, Baez FO, Aponte DV, Tomashek KM, Gutierrez J, Alvarado L. Utility of the tourniquet test and the white blood cell count to differentiate dengue among acute febrile illnesses in the emergency room. PLoS Negl Trop Dis. 2011;5:e1400. - PMC - PubMed
    1. Bruce MG, Sanders EJ, Leake JA, Zaidel O, Bragg SL, Aye T, Shutt KA, Deseda CC, Rigau-Perez JG, Tappero JW, Perkins BA, Spiegel RA, Ashford DA. Leptospirosis among patients presenting with dengue-like illness in Puerto Rico. Acta Trop. 2005;96:36–46. - PubMed
    1. WHO, TDR . Dengue Guidelines for Diagnosis, Treatment, Prevention and Control: New edition. 2009. http://www.who.int/rpc/guidelines/9789241547871/en/ Available at. - PubMed

Publication types

Cite

AltStyle によって変換されたページ (->オリジナル) /